Homology Medicines Analysis
| FIXXDelisted Stock | USD 1.09 0.06 5.83% |
Homology Medicines is overvalued with Real Value of 0.88 and Hype Value of 1.09. The main objective of Homology Medicines delisted stock analysis is to determine its intrinsic value, which is an estimate of what Homology Medicines is worth, separate from its market price. There are two main types of Homology Medicines' stock analysis: fundamental analysis and technical analysis.
The Homology Medicines stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Homology Medicines is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Homology Stock trading window is adjusted to America/New York timezone.
Homology |
Homology Stock Analysis Notes
About 47.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.04. Some equities with similar Price to Book (P/B) outperform the market in the long run. Homology Medicines recorded a loss per share of 35.1. The entity had not issued any dividends in recent years. The firm had 1:18 split on the 25th of March 2024. Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts. Homology Medicines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 224 people. To learn more about Homology Medicines call the company at 781 301 7277 or check out https://www.homologymedicines.com.Homology Medicines Investment Alerts
| Homology Medicines is now traded under the symbol QTTB. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Homology Medicines is not yet fully synchronised with the market data | |
| Homology Medicines has some characteristics of a very speculative penny stock | |
| Homology Medicines has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.16 M. Net Loss for the year was (112.96 M) with loss before overhead, payroll, taxes, and interest of (95.14 M). | |
| Homology Medicines currently holds about 201.07 M in cash with (96.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Homology Medicines Upcoming and Recent Events
Earnings reports are used by Homology Medicines to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Homology Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.02 M.Homology Medicines Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Homology Medicines insiders, such as employees or executives, is commonly permitted as long as it does not rely on Homology Medicines' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Homology Medicines insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Arthur Tzianabos over six months ago Exercise or conversion by Arthur Tzianabos of 14280 shares of Homology Medicines subject to Rule 16b-3 | ||
Arthur Tzianabos over a year ago Sale by Arthur Tzianabos of 10616 shares of Homology Medicines | ||
Smith W Bradford over a year ago Acquisition by Smith W Bradford of 213000 shares of Homology Medicines subject to Rule 16b-3 |
Homology Medicines Outstanding Bonds
Homology Medicines issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Homology Medicines uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Homology bonds can be classified according to their maturity, which is the date when Homology Medicines has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View |
Homology Medicines Predictive Daily Indicators
Homology Medicines intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Homology Medicines stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Homology Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Homology Medicines prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Homology shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Homology Medicines. By using and applying Homology Stock analysis, traders can create a robust methodology for identifying Homology entry and exit points for their positions.
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts. Homology Medicines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 224 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Homology Medicines to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Homology Stock
If you are still planning to invest in Homology Medicines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Homology Medicines' history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |